Moderna’s land grab

A blockbuster IPO by Moderna Inc. (NASDAQ:MRNA) gives the company the opportunity to make the case for mRNA.

With more money, and a broader and more advanced pipeline than other players in the mRNA space, Moderna could establish itself as a leader across several treatment paradigms. But it needs to prove itself with data. ...